Analyst Ratings For Zosano Pharma Corp (NASDAQ:ZSAN) Today, Piper Jaffray Companies initiated coverage on Zosano Pharma Corp (NASDAQ:ZSAN) with a Overweight. There are 1 hold rating, 2 buy ratings on the stock. The current consensus rating on Zosano Pharma Corp (NASDAQ:ZSAN) is Buy (Score: 2.67) with a consensus target price of $3.00 per share, a [
"Global Transdermal Patch Market& Clinical Pipeline Outlook 2022" report discusses the ongoing clinical and non-clinical parameters with respect to development of global transdermal patch market. Report highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies.
-CURE Pharmaceutical, or, a leading disruptive drug delivery technology company serving the pharmaceutical, biotech, veterinarian, medical foods markets, cannabinoid molecules and new chemical entities, today announces the appointment of Michael Neely, MD, 47, to its Advisory Board. Michael Neely, MD, currently serves as acting chief of infectious
By a News Reporter-Staff News Editor at Drug Week Sobi, a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families, announced that the FDA approved a supplemental new drug application for Orfadin capsules in the U.S. The sNDA will allow
OSAKA, Japan& FLORHAM PARK, N.J.& STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration approved Symproic 0.2 mg tablets C-II as a once-daily oral peripherally-acting mu-opioid receptor antagonist medication for the treatment of opioid-induced constipation in adult patients with chron
Release date- 23032017- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. today announced that the US Food and Drug Administration has approved BAVENCIO Injection 20 mg/mL, for intravenous use, for the treatment of adults and pediatric patients 12 years and older with metastatic Merke
Release date- 23032017- WINNIPEG- Medicure Inc., a leading Canadian specialty pharmaceutical company, is pleased to announce that its majority-owned subsidiary, Apicore Inc., has received final approval from the U.S. Food and Drug Administration for the Company's abbreviated new drug application for tetrabenazine tablets in the 12.5 mg and 25 mg st
Global Microelectronic medical implants market which is expected to reach USD 36.8 billion from USD 22.6 billion from 2015 to 2022, global microelectronic medical implants market is growing at rapid pace and is expected to grow at steady pace at the CAGR of 7.8%. *Abiomed Inc* Biomet Inc.* Cyberonics Inc.* Envoy Medical* Medtronic Inc* Microsemi Co
By a News Reporter-Staff News Editor at Drug Week- Mylan N.V., announced the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version of Pfizer's Pristiq Tablets. Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, had U.S. sales of approximately $853 million for the 12 months ending January 31, 2017,
New Findings from Northeastern University in the Area of Drug Delivery Systems Described. According to news reporting originating from Shenyang, People's Republic of China, by NewsRx correspondents, research stated, "A protein-stabilized multifunctional theranostic nanoplatform, gadolinium oxide-gold nanoclusters hybrid, is constructed for...
New Findings Reported from University of Alexandria Describe Advances in Drug Delivery Systems. According to news originating from Alexandria, Egypt, by NewsRx editors, the research stated, "There is an increasing interest to develop new nanocarriers that are capable of controlled and targeted drug delivery. Our news journalists obtained a quote fr
By a News Reporter-Staff News Editor at Drug Week New research on Nanotechnology- Nanoparticles is the subject of a report. According to news reporting out of Trois Rivieres, Canada, by NewsRx editors, research stated, "PAMAM dendrimers form strong protein conjugates that are used in drug delivery systems. Financial support for this research came
By a News Reporter-Staff News Editor at Drug Week Researchers detail new data in Drugs and Therapies- Cardiovascular Agents. According to news originating from Gyongsan, South Korea, by NewsRx correspondents, research stated, "The objective of this study was to develop a novel solid self-nanoemulsifying drug delivery system using a membrane emuls
Studies from Brandeis University in the Area of Drug Delivery Systems Reported. The news reporters obtained a quote from the research from Brandeis University, "As the first step towards that objective, we choose to develop self-assembled hydrogels of glycoconjugates that consist of anti-inflammatory drugs and glycopeptides. For more information on
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery. According to news reporting originating from Zhenjiang, People's Republic of China, by NewsRx correspondents, research stated, "Ginkgo biloba extract, the fifth generation extract of Ginkgo biloba, has been widely used in clin
According to news originating from Tabriz, Iran, by NewsRx correspondents, research stated, "Dysfunction of inner ear can result in from several disease procedures and introduce a possibility for therapeutic intervention. Our news journalists obtained a quote from the research from the Tabriz University of Medical Sciences, "Several strategies have
Study Results from Chonnam National University in the Area of Drug Delivery Systems Reported. According to news originating from Gwangju, South Korea, by NewsRx correspondents, research stated, "To improve drug delivery efficiency in cancer therapy, many researchers have recently concentrated on drug delivery systems that use anticancer drug loaded
According to news reporting from Lahore, Pakistan, by NewsRx journalists, research stated, "Microelectromechanical systems and micro total analysis systems revolutionized the biochemical and electronic industries, and this miniaturization process became a key driver for many markets. Financial support for this research came from Science and...
By a News Reporter-Staff News Editor at Drug Week Engineers at Carnegie Mellon University and biomedical researchers at the University of Pittsburgh and Magee-Womens Research Institute have established a framework for understanding the mechanics that underlie vesicle formation. The Carnegie Mellon engineers, including Subra Suresh, K. Jimmy Hsia,
Aeolus Pharmaceuticals, Inc., a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve damage and infection announced today that it received a response from the Assistant Secretary for Preparedness and Response that the Biomedical Advanced Research and Development Authority elected not to exercise additional...
-Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Joseph J. Sarret, M.D., Chief Business Officer, will participate in a BioPharma Dealmakers webcast featuring five companies innovating drug delivery technolog
As reported by Credence Research, Inc. through their latest publication "Global Drug Delivery Technologies Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016- 2022," the drug delivery technologies market was valued at USD 175.95 Bn in 2015, and is expected to reach USD 284.71 Bn by 2022, expanding at a CAGR of 6.9% from
In the latest report published by Credence Research, Inc. "Global Infusion Pumps Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016- 2022," the infusion pumps market was valued at USD 3,325.15 Mn in 2015, and is expected to reach USD 4,698 Mn by 2022, expanding at a CAGR of 5.2% from 2016 to 2022.. Infusion pumps represe
CURE Pharmaceutical, or, a leading disruptive drug delivery technology company serving the pharmaceutical, biotech, veterinarian, medical foods markets, cannabinoid molecules and new chemical entities, today announces the appointment of Michael Neely, MD, 47, to its Advisory Board. By joining CURE's advisory board, I'm truly excited by the pro
The report Disposable Medical Devices Market: Materials Application End-User- Forecast, published by IndustryARC, estimates that owing to the higher emphasis on high quality health care especially in North America, the market is set to experience a steep rise specifically in developing countries such as India and China along with Europe.